Clinical Trials Browser

Phase 1 × Brain Neoplasms × Cytarabine × Clear all

NCT03654716 2025-02-14

Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer

Phase 1 Completed

CNSLymphoidOther hematologic neoplasm

Brain Neoplasms, Leukemia, Lymphoma